Ahmad Taqi
Ahmad_Taqi
Remdesivir for COVID-19. Single arm study, very difficult to make any conclusions from it, will have to wait on the ongoing RCT..https://www.nejm.org/doi/full/10.1056/NEJMoa2007016 للأسف قد تكون هذه أسوأ ورقة عملية تنشر
Read more